Hyperphosphatemia Market By Product Type (Calcium-Based Phosphate Binders, Non-Calcium-Based Phosphate Binders, Others); By Indication (Chronic Kidney Disease (CKD), End-Stage Renal Disease (ESRD), Acute Kidney Injury (AKI), Others); By End User (Hospitals, Dialysis Centers, Specialty Clinics, Homecare Settings, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The Global Hyperphosphatemia Market is projected to grow from $4.3 billion in 2024 to $5.7 billion by 2030, registering a CAGR of 4.8% during the forecast period. The market growth is fueled by the growing global dialysis population, increasing CKD awareness, and expanding reimbursement for novel... Read More

In-Silico Drug Discovery Market By Workflow (Preclinical, Clinical, Discovery); By Therapeutic Area (Oncology, Central Nervous System (CNS), Infectious Disease, Cardiovascular); By End User (CROs, Pharma & Biotech, Academic Institutes, Government/Non-Profit Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The Global In-Silico Drug Discovery Market is projected to grow from $3.6 billion in 2024 to $6.8 billion by 2030, registering a CAGR of 11.2% during the forecast period. This surge is underpinned by the rising adoption of AI-led platforms, increasing pharmaceutical R&D digitization, and the ... Read More

Epigenetics Market By Product (Reagents, Instruments, Software & Services); By Technology (DNA Methylation, Histone Modification, RNA Associated Silencing, Others); By Application (Cancer Research, Age-related Diseases, Precision Medicine, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The Global Epigenetics Market is projected to grow from $2.3 billion in 2024 to $5.1 billion by 2030, registering a CAGR of 13.4% during the forecast period. Epigenetics examines heritable and stable modifications in gene expression that result from changes in the chromosome rather than alteratio... Read More

Natural Killer (NK) Cell Therapeutics Market By Therapeutic Type (NK Cell Engagers, CAR-NK Cell Therapy, NK Cell Therapy [Unmodified]); By Indication (Cancer, Immunoproliferative Disorders, Gastrointestinal Diseases, Others); By End User (Hospitals, Research Centers & Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The Global Natural Killer (NK) Cell Therapeutics Market is projected to grow from $1.6 billion in 2024 to $3.9 billion by 2030, registering a CAGR of 17.3% during the forecast period. Natural killer (NK) cells are a type of innate lymphoid cell that targets and eliminates infected or diseased cel... Read More

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market By Product Type (Implant grade, Non-implant grade); By Application (Total Hip Replacement, Total Knee Replacement, Others); By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Report Insights

The Global Medical Grade UHMWPE Market is projected to grow from $2.4 billion in 2024 to $4.1 billion by 2030, registering a CAGR of 8.8% during the forecast period. Ultra-High Molec... Read More

RNA Therapeutics Market By Type (mRNA (Messenger RNA), ASO (Antisense Oligonucleotides), siRNA (Small Interfering RNA), Aptamers, Others); By Product (Vaccines, Drugs); By Indication (Rare Genetic Diseases, Infectious Diseases, Other Indications); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

RNA Therapeutics Market Introduction

The Global RNA Therapeutics Market is projected to grow from $13.5 billion in 2024 to $43.1 billion by 2030, registering a CAGR of 21.3% during the forecast period. RNA molecules have gained attention as powerful clinical therapeut... Read More

Neurothrombectomy Devices Market By Product Type (Clot Retrievers, Vascular Snares, Aspiration/Suction Devices, Others); By Technique (Mechanical Thrombectomy, Aspiration Thrombectomy, Combined Techniques); By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Neurothrombectomy Devices Market Size

The global neurothrombectomy devices market is projected to grow from $736.3 million in 2024 to $1,093.5 million by 2030, registering a CAGR of 6.8% during the forecast period. This steady growth reflects the rising demand for ra... Read More

Alzheimer’s Disease Therapeutics And Diagnostics Market By Product (Diagnostics [Biomarker Analysis, Imaging Techniques (MRI, PET), Genetic Testing, Digital Diagnostics, Blood-Based Assays], Therapeutics [Cholinesterase Inhibitors, NMDA Receptor Antagonists, Anti-Amyloid Monoclonal Antibodies, Tau Aggregation Inhibitors, Disease-Modifying Therapies]); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Alzheimer’s Disease Therapeutics And Diagnostics Market Size

The Global Alzheimer’s Disease Therapeutics & Diagnostics Market is on the cusp of a transformative decade. In 2024, the market was valued at USD 11.40 billion, and by 2030, it is projected ... Read More

Oncology Biosimilars Market By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Blood Cancer, Cervical Cancer, Others); By Drug Class (Monoclonal Antibodies, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor); By Route of Administration (Subcutaneous, Intravenous, Others); By Distribution Channel (Online Pharmacy, Hospital Pharmacy, Retail Pharmacy, Others), Segment Revenue Estimation, Forecast, 2024–2032.

Oncology Biosimilars Market Size

The Oncology Biosimilars Market size was valued at USD 6.8 billion in 2024 and is projected to reach around USD 21.1 billion by 2030, expanding at a CAGR of 20.3%, the growth is driven by the rising cancer prevalence, increasing deman... Read More

Biosimilars Market By Molecule Class (Monoclonal Antibodies [Trastuzumab, Bevacizumab, Rituximab, Adalimumab, Others]; Insulin [Glargine, Aspart]; Hematologic [Filgrastim, Pegfilgrastim, Epoetin, Alfa]); By Indication (Oncology, Autoimmune Disorders, Diabetes, Blood Disorders, Ophthalmology, Endocrine and Hematologic Disorders, Others); By Route of Administration (Intravenous, Subcutaneous, Extended Delivery Formats); By End-User (Hospitals & Cancer Centers, Ambulatory Clinics, Specialty Pharmacies, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Biosimilars Market Size & Overview

The Global Biosimilars Market was valued at USD 24.5 billion in 2023 & is projected to reach around USD 74.3 billion by 2030, expanding at a CAGR of 21.1% during the forecast period. The growth is being driven by the rising g... Read More